Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-13
2007-03-13
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S506000, C514S553000, C514S557000, C514S561000
Reexamination Certificate
active
10602413
ABSTRACT:
The invention relates to a method of preventing or treating cartilage damage by administering a GABA analog such as, for example, a compound of Formulaand pharmaceutically acceptable salts thereof, wherein R1is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.
REFERENCES:
patent: 4024175 (1977-05-01), Satzinger et al.
patent: 4087544 (1978-05-01), Satzinger et al.
patent: 5518730 (1996-05-01), Fuisz
patent: 5563175 (1996-10-01), Silverman et al.
patent: 5703119 (1997-12-01), Baragi et al.
patent: 6001876 (1999-12-01), Singh
patent: 6127418 (2000-10-01), Bueno et al.
patent: 6329429 (2001-12-01), Schrier et al.
patent: 6506785 (2003-01-01), Evans et al.
patent: 60036413 (1985-02-01), None
patent: 9803167 (1998-01-01), None
patent: 9817627 (1998-04-01), None
patent: 9858641 (1998-12-01), None
patent: 9919296 (1999-04-01), None
patent: 9931057 (1999-06-01), None
patent: 9931074 (1999-06-01), None
patent: 9931075 (1999-06-01), None
patent: 9937296 (1999-07-01), None
patent: 9961424 (1999-12-01), None
patent: 0076958 (2000-12-01), None
patent: 0128978 (2001-04-01), None
Minor, Marian A. “Arthritis and Exercise: The Times They are A-Changin'”, Arthritis and Rheumatism, vol. 9, No. 2, Apr. 1996 pp. 79-81.
The Merck Manual, Seventeenth Edition, 1999, Published by Merck Research Laboratories, p. 451.
Lu, Ying, et al., “Gabapentin Attenuates Nociceptive Behaviors in an Acute Arthritis Model in Rats”, J.Pharm. & Exper. Ther., vol. 290, No. 1, pp. 214-219.
Reginster, Jean Y. et al., “Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial”,The Lancet, vol. 357, 2001, pp. 251-256.
Schrier Denis
Welgus Howard Glenn
Wustrow David Juergen
Ashbrook Charles W.
Crissey Todd M.
Jiang Shaojia Anna
Olson Eric
Purchase, Jr. Claude F.
LandOfFree
Method of treating noninflammatory cartilage damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating noninflammatory cartilage damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating noninflammatory cartilage damage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3794581